FTSE 100 subdued as energy, healthcare stocks limit broader gains

By Reuters News

- Britain's FTSE 100 was muted on Monday as gains across broader sectors were countered by declines in heavyweight energy and healthcare stocks, as investors awaited the Bank of England's interest rate decision this week.

The blue-chip FTSE 100 index .FTSE was flat at 10,731.34 points by 1130 GMT, while the midcap FTSE 250 .FTMC climbed 0.7%.

  • Oil prices dropped over 4% with Brent crude trading around $108 a barrel, as talks between Iran and Qatar raised hopes of an end to the US-Iran war O/R

  • The energy sector .FTNMX601010 fell 1.2%, with Ithaca Energy ITH.L and BP BP.L down 2.2% and 1.5%, respectively, among the bottom performers on the FTSE 100

  • Pharma stocks .FTNMX201030 declined 0.6% after gaining over 5% on Friday, their biggest single-day gain in about 13 months

  • The retreat in oil lifted broader risk appetite with aerospace and defence .FTNMX502010 up 0.8% and the consumer-facing personal care, drug and grocery .FTNMX452010 and beverages .FTNMX451010 sectors rising 0.7% and 0.8%, respectively

  • The Bank of England's interest rate decision will be in focus this week, with the central bank expected to raise rates by 25 basis points

  • Higher-than-expected inflation in September sealed the case for tighter monetary policy. It was underscored by data on Monday showing British manufacturers recorded their strongest output growth in more than two years in October

  • The FTSE 100 marked its first monthly gain in three months in October, outperforming the US benchmark S&P 500 that lost close to 1% due to a selloff in AI stocks

  • Finance minister John Healey's first budget presented less-severe-than-expected tax hikes on banks and gambling firms as well as funding for Britain's defence plan, sparking a rally in those stocks last week

  • Public transport operator FirstGroup FGP.L rose 4.8% after agreeing to sell certain assets to the West Yorkshire Combined Authority for £109 million ($145.95 million), helping support the midcap index

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.